Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vanillin is a naturally occurring phenolic aldehyde and the primary chemical component of vanilla bean extract. It is widely recognized as a flavoring agent and fragrance in the food and cosmetic industries, but it also possesses diverse biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. In clinical research, vanillin is being investigated as a therapeutic agent for viral diseases; specifically, it has been studied in an oral formula combined with wheat germ oil to treat mild-to-moderate COVID-19 and prevent its progression to severe disease. Additionally, vanillin is utilized in dental research as a natural crosslinking agent to stabilize demineralized dentin collagen and serves as a versatile building block for the synthesis of pharmaceutical derivatives and sustainable lignin-based polymers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vanillin.